ARTICLE | Clinical News
Kengrexal cangrelor regulatory update
April 13, 2015 7:00 AM UTC
The European Commission approved Kengrexal cangrelor from The Medicines Co. to reduce thrombotic cardiovascular events in patients with coronary artery disease (CAD) undergoing percutaneous coronary i...